Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Benign Hyperplasia of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01673490
What this trial is testing

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 59
Not applicableStudy completedNCT01381510
What this trial is testing

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

Who this might be right for
Prostatic Hyperplasia
GlaxoSmithKline 54,459
Testing effectiveness (Phase 2)Study completedNCT01939184
What this trial is testing

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Who this might be right for
Benign Prostatic Hyperplasia
Warner Chilcott 796
Not applicableStudy completedNCT01294150
What this trial is testing

The Safety and Effectiveness of UroLift: LIFT Pivotal Study

Who this might be right for
Benign Prostatic Hyperplasia
NeoTract, Inc. 206
Testing effectiveness (Phase 2)Ended earlyNCT02396420
What this trial is testing

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

Who this might be right for
Prostatic Hyperplasia
South Florida Medical Imaging, PA 2
Large-scale testing (Phase 3)Study completedNCT03902080
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Overactive Bladder
Urovant Sciences GmbH 1,105
Post-approval studies (Phase 4)WithdrawnNCT05393921
What this trial is testing

The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder

Who this might be right for
Benign Prostatic HyperplasiaOveractive Bladder
University Hospitals Cleveland Medical Center
Testing effectiveness (Phase 2)Study completedNCT00540124
What this trial is testing

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 151
Not applicableLooking for participantsNCT06852859
What this trial is testing

Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia

Who this might be right for
Benign Prostatic Hyperplasia
Sahlgrenska University Hospital 500
Post-approval studies (Phase 4)Study completedNCT02431754
What this trial is testing

Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 171
Not applicableStudy completedNCT01435954
What this trial is testing

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

Who this might be right for
Benign Prostatic Hyperplasia
GlaxoSmithKline 13,551
Post-approval studies (Phase 4)Study completedNCT03144596
What this trial is testing

The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

Who this might be right for
Benign Prostatic HyperplasiaPupil AnomalyChoroid Disease
Kocatepe University 63
Not applicableStudy completedNCT05834270
What this trial is testing

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Who this might be right for
Prostatic NeoplasmsProstate DiseaseProstate Obstruction+1 more
Menoufia University 60
Not applicableStudy completedNCT00861588
What this trial is testing

Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia

Who this might be right for
Benign Prostate Hyperplasia
Chinese University of Hong Kong 176
Post-approval studies (Phase 4)Study completedNCT02656173
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Who this might be right for
Overactive Bladder
Astellas Pharma Inc 568
Not applicableStudy completedNCT04383093
What this trial is testing

Tadalafil Plus Tamsulosin for Male LUTS and ED

Who this might be right for
Prostatic Hyperplasia, BenignLower Urinary Tract SymptomsErectile Dysfunction+1 more
University of Florence 75
Large-scale testing (Phase 3)Study completedNCT00670306
What this trial is testing

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Benign Prostatic Hypertrophy
AEterna Zentaris 528
Not applicableWithdrawnNCT04563221
What this trial is testing

Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
Andrew Picel
Post-approval studies (Phase 4)Study completedNCT00143221
What this trial is testing

Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Impotence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 350
Testing effectiveness (Phase 2)Study completedNCT01446991
What this trial is testing

Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 50
Next Page